scorecardresearchSyngene International Share Price Live NSE, BSE, Today - Syngene International

Syngene International

BSE: 539268 | NSE: SYNGENE | ISIN: INE398R01022 | SECTOR: Biotechnology & Drugs

701.00 6.95 (1%)

22 May 2024, 09:59 (IST)
  • Open

  • High

  • Low

  • Prev Close

  • P/E

  • Median P/E

  • P/B

  • Median P/B

  • Market Cap

  • Volume

  • Vol. (20 day Avg.)

  • PEG

  • Div.Yield

  • Bid

  • Ask


Company Description

  • Biotechnology & Drugs
  • BSE

  • NSE

  • ISIN


Syngene International Limited is an integrated research, development, and manufacturing services company. The Company is engaged in providing contract research and manufacturing services from lead generation to clinical supplies to pharmaceutical and biotechnology companies worldwide. Its services include drug discovery and development capabilities in medicinal chemistry, biology, in vivo pharmacology, toxicology, custom synthesis, process research and development, current good manufacturing practice (cGMP) manufacturing, formulation, and analytical development, along with clinical development services. It offers SynVent, a therapeutic discovery and development platform for executing drug discovery projects. SynVent's portfolio covers modalities and therapeutic areas ranging from small molecule inhibitors to targeted protein stabilization. It serves the pharmaceutical, biotechnology, and specialty chemical sectors, among others. It operates multi-modal biologics manufacturing facility.

Company Officers

  • Jonathan Hunt

    Chief Executive Officer, Managing Director, Executive Director
  • Sibaji Biswas

    Chief Financial Officer, Executive Director
  • Andrew Webster

    Chief Human Resource Officer
  • Kenneth Barr

    Senior Vice President - Discovery Services
  • Alex Del Priore

    Senior Vice President - Manufacturing Services
  • Priyadarshini Mahapatra

    Compliance Officer, Company Secretary
  • Caroline Hempstead

    Head of Corporate Affairs
  • Alok Mehrotra

    Chief Quality Officer